GENERAL COMMENTS
It is believed that socioeconomic improvements is associated with a declining trend of RHD. However, echocardiographic studies during last decade have indicated a high prevalence of RHD in the populations earlier considered to be having a low prevalence. A change in methods of ascertaining the prevalence/ incidence of RHD in 1992 probably led to missing out of cases of RHD during mass screening in population and any hospital based diagnostic screening survey. So, a systemic review not differentiating echo screening studies from erstwhile clinical screening/clinical screening echo confirmed studies certainly is redundant. Use of any statistics can not correct the bias due to these above mentioned antagonistic screening methods.
Authors want to use outdated methods for review. Their main wish is to generate evidence on trend of RHD in South Africa. Obvious limitations in the protocol almost completely preclude any such possibility.
Please, resubmit a protocol only focusing solely on echocardiography only studies, as earlier clinical/clinically screened echo confirmed studies are a almost sure underestimate. Again one should never forget that for chronic conditions prevalence/incidence of condition is almost complete correlate of availability of screening facilities in the country. Reported increased prevalence of cervical cancer, prostate cancer and diabetes in well screened communities are reminders of ecological fallacies committed. GENERAL COMMENTS This is a methods paper describing forthcoming work and does not all questions apply.
REVIEWER
Use of RHD registers versus vital registration; why eliminate the registers and keep the vital registration. The reason not to consider registers is supported by one single reference.
How will unpublished work be valued compared to information obtained from published work? This should be stated in the paper.
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GENERAL COMMENTS
Recently, the World Heart Federation emphasized that high-quality, country-specific data on the mortality and morbidity of rheumatic heart disease was critical for determining local priorities and public health planning. South Africa is unique within sub-Saharan Africa in that there are large income and likely burden of disease dependencies within the population. And, uniquely, as the authors mentioned, the last 20 years in South Africa have seen efforts to improve primary healthcare for all of its people. This makes the systematic review proposed here quite important. Data from this review will provide longitudinal data for South Africa. But, it could also provide an example of the overall impact of healthcare strengthening on the burden of RHD in Africa.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1: Maneesha Bhaya Specific comments: It is believed that socioeconomic improvements is associated with a declining trend of RHD. However, echocardiographic studies during last decade have indicated a high prevalence of RHD in the populations earlier considered to be having a low prevalence. A change in methods of ascertaining the prevalence/ incidence of RHD in 1992 probably led to missing out of cases of RHD during mass screening in population and any hospital based diagnostic screening survey. So, a systemic review not differentiating echo screening studies from erstwhile clinical screening/clinical screening echo confirmed studies certainly is redundant. Use of any statistics can not correct the bias due to these above mentioned antagonistic screening methods.
Thank you for this comment. The reviewer is correct in that prevalence studies have included subclinical cases detected by auscultation, auscultation and echocardiography and only echocardiography. In fact, the corresponding author has recently published several manuscripts on these methods. [1] [2] [3] We have thus elected to add in a paragraph stating the difference between screening studies and hospital-based clinical studies. See line 101-105 in the inclusion criteria. We will also endeavour to comprehensively report on the diagnostic methods of any prevalence and incidence study in order to reduce any bias relating to antagonistic screening methods. We have therefore also added an additional sentence under prevalence line 201-204 where we mention the cross-walking procedure to adjust prevalence estimates from the different studies, report these effects on pooled estimates separately and thus reduce attached bias.
[4] Further more we stress that the morbidity and mortality data are from symptomatic populations, rather than asymptomatic populations.
Please, resubmit a protocol only focusing solely on echocardiography only studies, as earlier clinical/clinically screened echo confirmed studies are a almost sure underestimate. Again one should never forget that for chronic conditions prevalence/incidence of condition is almost complete correlate of availability of screening facilities in the country. Reported increased prevalence of cervical cancer, prostate cancer and diabetes in well screened communities are reminders of ecological fallacies committed.
Thank you for this comment; the scope of this review cannot be changed in its entirety. However we will consider these comments in our analysis phase, based on the outcome of the planned searches. In our completed review, we will address the limitations in terms of generation of evidence of trend.
